ArticleJournal of cardiothoracic surgery2025
Factors contributing to transient and persistent worsening renal function in elderly patients with acute decompensated heart failure.
Article in Journal of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study is to analyze the distinct characteristics and risk factors contributing to the development of worsening renal function (WRF) in elderly patients with acute decompensated heart failure (ADHF), while also examining the subset of persistent WRF among elderly patients with ADHF.
methodsIn this retrospective study, patients were stratified into two groups, non-WRF and WRF, based on alterations in creatinine levels. Subsequently, the WRF group was further delineated into transient and persistent WRF subgroups, contingent upon temporal changes in creatinine levels. There 218 elderly ADHF patients aged ≥ 60 years old, with an average age of (72.11 ± 7.94) years old. Among them, 66 patients with ADHF developed WRF during hospitalization, with an incidence of 30.28%. Among the 66 WRF patients, 20 cases were transient WRF and 46 cases were persistent WRF. The study revealed notable distinctions within the WRF cohort, characterized by heightened smoking prevalence, significantly elevated brain natriuretic peptide (BNP) levels at admission, diminished hematocrit (HCT) levels and more applications. ACEI (angiotensin-converting enzyme inhibitors) or ARB (angiotensin receptor inhibitor) or ARNI (angiotensin receptor neprilysin inhibitor) drugs. Within the persistent WRF subgroup, patients were characterized by advanced age, predominantly male gender distribution, heightened incidence of coronary artery disease, and significantly elevated systolic blood pressure (SBP), uric acid, BNP, and glycosylated hemoglobin levels compared to their transient WRF counterparts, while displaying lower D-dimer levels. In multivariate analysis, BNP level (OR = 1.001, 95%CI 1.000-1.001; P = 0.032), D-dimer level (OR = 1.013, 95%CI 1.003–1.024; P = 0.013), ACEI or ARB or ARNI drugs (OR = 19.656, 95%CI 8.698–30.763; P = 0.009) were positively correlated with the occurrence of WRF. HCT level was negatively correlated with the occurrence of WRF (OR = 0.850, 95%CI 0.744–0.970; P = 0.016). Systolic blood pressure (OR = 1.158, 95%CI 1.051–1.276; P = 0.003), D-dimer levels (OR = 0.998, 95%CI 0.997–0.999; P < 0.001) were associated with persistent WRF.
conclusionThe findings of this study indicate a clear association between BNP, HCT, D-dimer levels and ACEI or ARB or ARNI drugs and the emergence of WRF in elderly individuals with ADHF. Furthermore, the study underscores that persistent WRF is notably linked with systolic blood pressure and D-dimer levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.